199800.KQ
ToolGen Incorporated
KOE · Healthcare · Medical - Specialties · KR
KRW 33,400.00
−3.05%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.9B | 1.3B | 891.0M | 1.1B | 743.5M |
| Cost of Revenue | 2.8B | 1.9B | 217.9M | 168.4M | 185.1M |
| Gross Profit | (852.5M) | (574.0M) | 673.0M | 935.0M | 558.4M |
| Operating Expenses | |||||
| R&D Expense | 7.0B | 7.2B | 6.8B | 6.7B | 6.3B |
| SG&A Expense | 14.3B | 12.0B | 9.3B | 5.1B | 6.2B |
| General & Admin Expense | 180.5M | 316.6M | 445.0M | 504.7M | 257.2M |
| Selling & Marketing Expense | 8.6B | 11.6B | 8.8B | 4.6B | 6.0B |
| Other Expenses | 5.5B | 4.0B | 6.4B | 6.2B | 7.4B |
| Total Operating Expenses | 24.1B | 23.1B | 22.5B | 18.0B | 19.9B |
| Cost and Expenses | 25.9B | 25.0B | 22.7B | 18.2B | 20.1B |
| Operating Income (EBIT) | (23.9B) | (23.7B) | (21.8B) | (17.1B) | (19.4B) |
| Non-Operating | |||||
| Interest Income | 923.9M | 1.3B | 2.4B | 2.1B | 1.2B |
| Interest Expense | 16.2B | 16.9B | 2.6B | 428.2M | 28.4M |
| Net Interest Income | (15.3B) | (15.5B) | (176.1M) | 1.6B | 1.2B |
| Other Non-Op Income/Expense | (15.2B) | (13.1B) | 28.0B | (25.3B) | 1.2B |
| Non-Operating Income (excl Interest) | 15.2B | — | (30.6B) | 24.8B | (1.2B) |
| EBT (Pre-Tax Income) | (39.1B) | (36.8B) | 6.2B | (42.3B) | (18.2B) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (39.1B) | (36.8B) | 6.2B | (42.3B) | (18.2B) |
| Earnings from Cont. Ops | (39.1B) | (36.8B) | 6.2B | (42.3B) | (18.2B) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (39.1B) | (36.8B) | 6.2B | (42.3B) | (18.2B) |
| Per Share | |||||
| Basic EPS | (₩4,374) | (₩4,099) | ₩776 | (₩5,351) | (₩2,314) |
| Diluted EPS | (₩4,374) | (₩4,099) | ₩776 | (₩5,351) | (₩2,314) |
| Revenue Per Share | ₩209 | ₩146 | ₩112 | ₩139 | ₩95 |
| Shares | |||||
| Basic Shares Outstanding | 9.1M | 9.0M | 7.9M | 7.9M | 7.9M |
| Diluted Shares Outstanding | 9.1M | 9.0M | 7.9M | 7.9M | 7.9M |
| Profitability Metrics | |||||
| EBITDA | (21.8B) | (21.9B) | 10.6B | (40.4B) | (18.3B) |
| D&A | 1.8B | 1.8B | 1.8B | 1.5B | 1.1B |
| EBIT | (23.6B) | (23.7B) | 8.8B | (41.9B) | (19.4B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026